Claims
- 1. A method for lowering triglycerides in a subject comprising the administration of a therapeutic amount of a hPPAR delta agonist of Formula (I) wherein X represents a COOH (or a hydrolysable ester thereof); X1 is O or S; X2 represents O or S; R1 and R2 independently represent H, CH3, OCH3, or halogen, n is 1 or 2, one of Y and Z is N and the other is S or O; y represents 1 or 2; each R3 independently represents CF3 or halogen.
Priority Claims (1)
Number |
Date |
Country |
Kind |
9914977 |
Jun 1999 |
GB |
|
Parent Case Info
This application is a continuation of application Ser. No. 10/018,935, filed Dec. 19, 2001 which is a rule 371 U.S. National Phase Application of PCT Application No. PCT/EP00/05720, filed Jun. 22, 2000, which claims priority to GB Application Serial No. 9914977.5, filed Jun. 25, 1999.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
5847008 |
Doebber et al. |
Dec 1998 |
A |
Foreign Referenced Citations (11)
Number |
Date |
Country |
53555 |
Feb 1995 |
JP |
165735 |
Jun 1995 |
JP |
104688 |
Apr 1996 |
JP |
325250 |
Dec 1996 |
JP |
124623 |
May 1997 |
JP |
194467 |
Jul 1997 |
JP |
323982 |
Dec 1997 |
JP |
WO 9728149 |
Aug 1997 |
WO |
WO 9807699 |
Feb 1998 |
WO |
WO 9904815 |
Feb 1999 |
WO |
WO 9946232 |
Aug 1999 |
WO |
Non-Patent Literature Citations (2)
Entry |
Shinkai Hisashi et al., Isoxazolidine-3,5-dione and Noncyclic 1,3-Dicarbonyl Compounds as Hypoglycemic Agents, J. Medicinal Chemistry, 1998, vol. 41, pp. 1927-1933. |
S.W. Bright et al., Monoclonal antibodies as surrogate receptors in a high throughput screen for compounds that enhance insulin sensitivity, Life Sciences, vol. 61, No. 23, pp. 2305-2315, 1997. |
Continuations (1)
|
Number |
Date |
Country |
Parent |
10/018935 |
|
US |
Child |
10/383011 |
|
US |